Strengthening HIV-prevention trials: a dose of implementation science?
| Publicado en: | Lancet Infectious Diseases Vol. 18; no. 11; pp. 1166 - 1169 |
|---|---|
| Autores principales: | , , |
| Formato: | commentary Journal Article |
| Publicado: |
Elsevier B.V.
Nov2018
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=133364795&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 133364795 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 14733099 KIL jtl: Lancet Infectious Diseases issn: 14733099 maglogo: N pubinfo: dt: Nov2018 vid: 18 iid: 11 pid: 467 pub: Elsevier B.V. place: New York, New York artinfo: ui: 133364795 133364795 NLM30507394 133364795 10.1016/S1473-3099(18)30567-X NLM30507394 133364795 ppf: 1166 ppct: 3 formats: tig: atl: Strengthening HIV-prevention trials: a dose of implementation science? aug: au: Geng, Elvin H Glidden, David V Padian, Nancy affil: University of California, San Francisco, CA 94117, USA sug: subj: HIV-1 HIV Infections Female South Africa Vaginal Creams, Foams and Jellies Double-Blind Studies Female pubtype: Academic Journal doctype: commentary Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|